Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|February 25, 2025
Post-recurrence survival in patients with stage III gastric cancer who received adjuvant chemotherapy; post-hoc analysis of the JACCRO GC-07 studyHiroo Ishida, Yu Sunakawa, Yasuhiro Kodera, et al.Oncotarget|September 17, 2017
TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC studyMasanori Terashima, Wataru Ichikawa, Atsushi Ochiai, et al.Oncology Letters|June 28, 2016
A comparison of four methods for detecting KRAS mutations in formalin-fixed specimens from metastatic colorectal cancer patientsMototsugu Matsunaga, Toshikado Kaneta, Keisuke Miwa, et al.Palliative & Supportive Care|February 20, 2008
A case of respiratory akathisia in a cancer patient: a case reportYu Sunakawa, Makoto Wada, Tomomi Nishida, et al.Cancer Medicine|December 23, 2023
Correlation of multiple endpoints in the first-line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trialsHiroyuki Arai, Madoka Takeuchi, Wataru Ichikawa, et al.Journal of Pharmaceutical Health Care and Sciences|November 16, 2016
Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in JapanKosuke Takata, Ken-Ichi Fujita, Yutaro Kubota, et al.Japanese Journal of Clinical Oncology|February 12, 2011
Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancerHiroo Ishida, Ken-Ichi Fujita, Yuko Akiyama, et al.Clinical Pharmacology and Therapeutics|February 9, 2020
Higher Systemic Exposure to Unbound Active Metabolites of Regorafenib Is Associated With Short Progression-Free Survival in Colorectal Cancer PatientsYutaro Kubota, Ken-Ichi Fujita, Takehiro Takahashi, et al.Anti-Cancer Drugs|April 7, 2007
Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancerTakao Katsube, Kenji Ogawa, Wataru Ichikawa, et al.Oncology|April 18, 2012
A phase I study of infusional 5-fluorouracil, leucovorin, oxaliplatin and irinotecan in Japanese patients with advanced colorectal cancer who harbor UGT1A1*1/*1,*1/*6 or *1/*28Yu Sunakawa, Ken-ichi Fujita, Wataru Ichikawa, et al.Pageof 8